Sunday - December 22, 2024

Il-2 Variants With Reduced Binding to IL-2 Receptor Alpha and Uses Thereof

2024-12-17

ALEXANDRIA, Virginia, Dec. 17 -- REGENERON PHARMACEUTICALS, INC., Tarrytown, New York has been assigned a patent (No. US 12168681 B2, initially filed Oct. 25, 2023) developed by four inventors Jiaxi Wu, Pleasantville, New York; Tong Zhang, New Rochelle, New York; Samuel Davis, New York, New York; and Nicolin Bloch, Ossining, New York, for "Il-2 variants with reduced binding to IL-2 receptor alpha and uses thereof." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Il-2 Variants With Reduced Binding to IL-2 Receptor Alpha and Uses Thereof

Information Request Form

Copyright Targeted News Service 2024